Trump Administration ‘Open For Business’ On Drug Imports From Canada
(By Phil Galewitz for Kaiser Health News) A year after calling proposals allowing Americans to import cheaper drugs from Canada
Read More
FDA
FDA approves Rituxan biosimilar
(By Alia Paavola for Becker’s Hospital Review) The FDA has approved Pfizer’s biosimilar to Rituxan, a treatment for some cancers and autoimmune
Read MoreFDA approves 1st Lyrica generics
(By Alia Paavola for Becker’s Hospital Review) The FDA has approved several new generics of Lyrica, a brand-name drug manufactured by Pfizer
Read MoreDrugmaker tried to shred records before FDA inspection, agency claims
(By Alia Paavola for Becker’s Hospital Review) FDA inspectors claim that Strides Pharma Science, an India-based drugmaker that sells numerous
Read MorePatient dies from fecal transplant, FDA warns
(By Alia Paavola for Becker’s Hospital Review) The FDA alerted healthcare providers June 13 that at least one patient has died after
Read MoreTeva expands nationwide recall of losartan
(By Alia Paavola for Becker’s Hospital Review) Teva Pharmaceuticals has recalled an additional six lots of bulk losartan potassium tablets,
Read MoreFed up with Washington, ALS advocates consider ACT UP’s take-no-prisoners approach
(By Nicholas Florko for STAT) WASHINGTON — Next Wednesday, a cadre of ALS patients will gather for a protest outside
Read MoreCancer Drugs Approved Quickly Often Fail To Measure Up Later
(By Richard Harris for NPR) Cancer drugs that speed onto the market based on encouraging preliminary studies often don’t show
Read MoreHidden Reports Masked The Scope Of Widespread Harm From Faulty Heart Device
(By Christina Jewett for Kaiser Health News) Faced with the possibility that a bout of abnormal heartbeats could end his
Read MoreMustang Bio’s brain cancer-targeting gene therapy granted FDA Orphan Drug designation
(By Andrea Park for Becker’s Hospital Review) A new gene therapy developed for the treatment of malignant glioma, a rare
Read More